The bridge from science to patient outcomes in oncology

In oncology, we have come to expect rapid, innovative clinical development that provides life-changing care for patients, expanding our definition of immuno-oncology. Keeping pace with the volume of information for oncologists is dizzying. The healthcare system too must continuously evolve to keep pace with the science. Pharma’s role in this rapidly evolving landscape is critical. In this webinar, we’ll discuss how pharma can bridge the gap between scientific progress and patient well-being.

Watch the webinar to gain a greater understanding of:

• Developments in some of the most active areas of clinical and commercial development: targeted radiopharmaceuticals, cancer vaccines and antibody drug conjugates
• The delivery challenges that advanced platforms face from those who are closest to care delivery
• How pharma can help treaters and hospitals convert potential to reality for advanced therapeutic platforms